Soo H. Choi

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Role of oncostatin M and its receptor in the inflammatory pathogenesis of graves' orbitopathy.

Role of oncostatin M and its receptor in the inflammatory pathogenesis of graves' orbitopathy.

Journal: Immunopharmacology and immunotoxicology
Published: April 06, 2026

Cerebral blood flow estimation using NIRS in cardiac arrest patients: correlation with ROSC outcomes.

Cerebral blood flow estimation using NIRS in cardiac arrest patients: correlation with ROSC outcomes.

Journal: Resuscitation
Published: October 22, 2025

Correction: Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy.

Correction: Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy.

Journal: Frontiers in endocrinology
Published: September 20, 2025

Therapeutic effect of IL-11 inhibition on the pathogenesis of thyroid eye disease.

Therapeutic effect of IL-11 inhibition on the pathogenesis of thyroid eye disease.

Journal: Journal of molecular endocrinology
Published: June 02, 2025

Nicotinamide N-Methyltransferase in the Inflammatory Pathogenesis of Graves' Orbitopathy.

Nicotinamide N-Methyltransferase in the Inflammatory Pathogenesis of Graves' Orbitopathy.

Journal: Investigative ophthalmology & visual science
Published: May 01, 2025

Therapeutic effect of nintedanib in orbital fibroblasts in patients with Graves' orbitopathy.

Therapeutic effect of nintedanib in orbital fibroblasts in patients with Graves' orbitopathy.

Journal: Immunopharmacology and immunotoxicology
Published: April 27, 2025

Role of SerpinA3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.

Role of SerpinA3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.

Journal: Investigative ophthalmology & visual science
Published: April 09, 2025

Compound C exerts a therapeutic effect on Graves' orbitopathy via AMPK‑independent pathways.

Compound C exerts a therapeutic effect on Graves' orbitopathy via AMPK‑independent pathways.

Journal: International journal of molecular medicine
Published: January 07, 2025

Role of Lysyl Oxidase-Like Protein 3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.

Role of Lysyl Oxidase-Like Protein 3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.

Journal: Investigative ophthalmology & visual science
Published: November 15, 2024

Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy.

Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy.

Journal: Frontiers in endocrinology
Published: November 13, 2024

Therapeutic role of physalin A in the pathogenesis of Graves' orbitopathy.

Therapeutic role of physalin A in the pathogenesis of Graves' orbitopathy.

Journal: Immunopharmacology and immunotoxicology
Published: November 04, 2024

Nucleus YAP expression as a prognostic biomarker for local recurrence in eyelid sebaceous carcinoma.

Nucleus YAP expression as a prognostic biomarker for local recurrence in eyelid sebaceous carcinoma.

Journal: Scientific reports
Published: July 14, 2024
Showing 1-12 of 19

Last Updated: 09/26/2026